Form 8-K - Current report:
SEC Accession No. 0001193125-25-010817
Filing Date
2025-01-23
Accepted
2025-01-23 07:15:17
Documents
15
Period of Report
2025-01-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d810501d8k.htm   iXBRL 8-K 35860
2 EX-99.1 d810501dex991.htm EX-99.1 20116
6 GRAPHIC g810501dsp006.jpg GRAPHIC 11175
  Complete submission text file 0001193125-25-010817.txt   210316

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20250123.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20250123_lab.xml EX-101.LAB 19500
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20250123_pre.xml EX-101.PRE 12162
18 EXTRACTED XBRL INSTANCE DOCUMENT d810501d8k_htm.xml XML 3965
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 25547623
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)